{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T13:52:50Z","timestamp":1777038770787,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":120,"publisher":"Springer US","isbn-type":[{"value":"9781071641873","type":"print"},{"value":"9781071641880","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4188-0_6","type":"book-chapter","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T18:03:07Z","timestamp":1729274587000},"page":"125-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Stereotyped B-Cell Receptor Immunoglobulins in B-Cell Lymphomas"],"prefix":"10.1007","author":[{"given":"Andreas","family":"Agathangelidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Roussos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Kardamiliotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotis","family":"Psomopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,19]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1146\/annurev.immunol.21.120601.141018","volume":"21","author":"N Chiorazzi","year":"2003","unstructured":"Chiorazzi N, Ferrarini M (2003) B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 21:841\u2013894","journal-title":"Annu Rev Immunol"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0065-230X(01)83004-9","volume":"83","author":"FK Stevenson","year":"2001","unstructured":"Stevenson FK, Sahota SS, Ottensmeier CH et al (2001) The occurrence and significance of V gene mutations in B cell-derived human malignancy. Adv Cancer Res 83:81\u2013116","journal-title":"Adv Cancer Res"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.semcancer.2013.07.006","volume":"23","author":"L-A Sutton","year":"2013","unstructured":"Sutton L-A, Agathangelidis A, Belessi C et al (2013) Antigen selection in B-cell lymphomas\u2014tracing the evidence. Semin Cancer Biol 23:399\u2013409","journal-title":"Semin Cancer Biol"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1098\/rstb.2000.0751","volume":"356","author":"D Dunn-Walters","year":"2001","unstructured":"Dunn-Walters D, Thiede C, Alpen B, Spencer J (2001) Somatic hypermutation and B\u2013cell lymphoma. Philos Trans R Soc Lond Ser B Biol Sci 356:73\u201382","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1006\/scbi.2001.0423","volume":"12","author":"P Ghia","year":"2002","unstructured":"Ghia P, Granziero L, Chilosi M, Caligaris-Cappio F (2002) Chronic B cell malignancies and bone marrow microenvironment. Semin Cancer Biol 12:149\u2013155","journal-title":"Semin Cancer Biol"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","volume":"14","author":"DW Scott","year":"2014","unstructured":"Scott DW, Gascoyne RD (2014) The tumour microenvironment in B cell lymphomas. Nat Rev Cancer 14:517\u2013534","journal-title":"Nat Rev Cancer"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/joim.12600","volume":"282","author":"M Jerkeman","year":"2017","unstructured":"Jerkeman M, Hallek M, Dreyling M et al (2017) Targeting of B-cell receptor signalling in B-cell malignancies. J Intern Med 282:415\u2013428","journal-title":"J Intern Med"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.it.2013.07.002","volume":"34","author":"JA Burger","year":"2013","unstructured":"Burger JA, Chiorazzi N (2013) B cell receptor signaling in chronic lymphocytic leukemia. Trends Immunol 34:592\u2013601","journal-title":"Trends Immunol"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1172\/JCI3009","volume":"102","author":"F Fais","year":"1998","unstructured":"Fais F, Ghiotto F, Hashimoto S et al (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 102:1515\u20131525","journal-title":"J Clin Invest"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F et al (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840\u20131847","journal-title":"Blood"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A et al (1999) Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848\u20131854","journal-title":"Blood"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/leu.2017.125","volume":"31","author":"R Rosenquist","year":"2017","unstructured":"Rosenquist R, Ghia P, Hadzidimitriou A et al (2017) Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations. Leukemia 31:1477\u20131481","journal-title":"Leukemia"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.leu.2404457","volume":"21","author":"P Ghia","year":"2007","unstructured":"Ghia P, Stamatopoulos K, Belessi C et al (2007) ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 21:1\u20133","journal-title":"Leukemia"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/leu.2011.49","volume":"25","author":"AW Langerak","year":"2011","unstructured":"Langerak AW, Davi F, Ghia P et al (2011) Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases. Leukemia 25:979\u2013984","journal-title":"Leukemia"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/s41375-022-01604-2","volume":"36","author":"A Agathangelidis","year":"2022","unstructured":"Agathangelidis A, Chatzidimitriou A, Chatzikonstantinou T et al (2022) Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL. Leukemia 36:1961\u20131968","journal-title":"Leukemia"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D et al (2018) iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 131:2745\u20132760","journal-title":"Blood"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1182\/blood.2019003453","volume":"135","author":"A Condoluci","year":"2020","unstructured":"Condoluci A, Terzi di Bergamo L, Langerbeins P et al (2020) International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia. Blood 135:1859\u20131869","journal-title":"Blood"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41375-020-0727-y","volume":"34","author":"MA Hoechstetter","year":"2020","unstructured":"Hoechstetter MA, Busch R, Eichhorst B et al (2020) Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group. Leukemia 34:1038\u20131051","journal-title":"Leukemia"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1182\/blood-2014-01-546150","volume":"123","author":"S Stilgenbauer","year":"2014","unstructured":"Stilgenbauer S, Schnaiter A, Paschka P et al (2014) Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. Blood 123:3247\u20133254","journal-title":"Blood"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S1470-2045(16)30051-1","volume":"17","author":"B Eichhorst","year":"2016","unstructured":"Eichhorst B, Fink A-M, Bahlo J et al (2016) First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial. Lancet Oncol 17:928\u2013942","journal-title":"Lancet Oncol"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1182\/bloodadvances.2021006434","volume":"6","author":"PM Barr","year":"2022","unstructured":"Barr PM, Owen C, Robak T et al (2022) Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia. Blood Adv 6:3440\u20133450","journal-title":"Blood Adv"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S1470-2045(22)00293-5","volume":"23","author":"CS Tam","year":"2022","unstructured":"Tam CS, Brown JR, Kahl BS et al (2022) Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial. Lancet Oncol 23:1031\u20131043","journal-title":"Lancet Oncol"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41375-021-01485-x","volume":"36","author":"JP Sharman","year":"2022","unstructured":"Sharman JP, Egyed M, Jurczak W et al (2022) Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-na\u00efve chronic lymphocytic leukemia. Leukemia 36:1171\u20131175","journal-title":"Leukemia"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/hon.3163_25","volume":"41","author":"O Al-Sawaf","year":"2023","unstructured":"Al-Sawaf O, Robrecht S, Zhang C et al (2023) Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized CLL14 study. Hematol Oncol 41:58\u201360","journal-title":"Hematol Oncol"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4049\/jimmunol.158.1.235","volume":"158","author":"TA Johnson","year":"1997","unstructured":"Johnson TA, Rassenti LZ, Kipps TJ (1997) Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 158:235\u2013246","journal-title":"J Immunol"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1182\/blood.V87.9.3869.bloodjournal8793869","volume":"87","author":"DG Efremov","year":"1996","unstructured":"Efremov DG, Ivanovski M, Siljanovski N et al (1996) Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood 87:3869\u20133876","journal-title":"Blood"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4049\/jimmunol.166.1.95","volume":"166","author":"GF Widhopf","year":"2001","unstructured":"Widhopf GF, Kipps TJ (2001) Normal B cells express 51p1 -encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells. J Immunol 166:95\u2013102","journal-title":"J Immunol"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1182\/blood-2002-11-3485","volume":"101","author":"G Tobin","year":"2003","unstructured":"Tobin G, Thunberg U, Johnson A et al (2003) Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted V\u03bb2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 101:4952\u20134957","journal-title":"Blood"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1182\/blood-2005-04-1511","volume":"106","author":"K Stamatopoulos","year":"2005","unstructured":"Stamatopoulos K, Belessi C, Hadzidimitriou A et al (2005) Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood 106:3575\u20133583","journal-title":"Blood"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1182\/blood-2004-03-0818","volume":"104","author":"GF Widhopf","year":"2004","unstructured":"Widhopf GF, Rassenti LZ, Toy TL et al (2004) Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 104:2499\u20132504","journal-title":"Blood"},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1182\/blood-2004-01-0132","volume":"104","author":"G Tobin","year":"2004","unstructured":"Tobin G (2004) Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 104:2879\u20132885","journal-title":"Blood"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.20040544","volume":"200","author":"BT Messmer","year":"2004","unstructured":"Messmer BT, Albesiano E, Efremov DG et al (2004) Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 200:519\u2013525","journal-title":"J Exp Med"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1172\/JCI19399","volume":"113","author":"F Ghiotto","year":"2004","unstructured":"Ghiotto F, Fais F, Valetto A et al (2004) Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 113:1008\u20131016","journal-title":"J Clin Invest"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","volume":"111","author":"F Murray","year":"2008","unstructured":"Murray F, Darzentas N, Hadzidimitriou A et al (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 111:1524\u20131533","journal-title":"Blood"},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1365-2141.2008.07469.x","volume":"144","author":"R Bomben","year":"2009","unstructured":"Bomben R, Dal Bo M, Capello D et al (2009) Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol 144:492\u2013506","journal-title":"Br J Haematol"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/leu.2009.186","volume":"24","author":"N Darzentas","year":"2010","unstructured":"Darzentas N, Hadzidimitriou A, Murray F et al (2010) A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia 24:125\u2013132","journal-title":"Leukemia"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","volume":"109","author":"K Stamatopoulos","year":"2007","unstructured":"Stamatopoulos K, Belessi C, Moreno C et al (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 109:259\u2013270","journal-title":"Blood"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","volume":"119","author":"A Agathangelidis","year":"2012","unstructured":"Agathangelidis A, Darzentas N, Hadzidimitriou A et al (2012) Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood 119:4467\u20134475","journal-title":"Blood"},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood.2020007039","volume":"137","author":"A Agathangelidis","year":"2021","unstructured":"Agathangelidis A, Chatzidimitriou A, Gemenetzi K et al (2021) Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. Blood 137:1365\u20131376","journal-title":"Blood"},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/bjh.12893","volume":"166","author":"J Malcikova","year":"2014","unstructured":"Malcikova J, Stalika E, Davis Z et al (2014) The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors. Br J Haematol 166:621\u2013625","journal-title":"Br J Haematol"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.3324\/haematol.2016.142968","volume":"101","author":"V Navrkalova","year":"2016","unstructured":"Navrkalova V, Young E, Baliakas P et al (2016) ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres. Haematologica 101:e369\u2013e373","journal-title":"Haematologica"},{"key":"6_CR42","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1038\/leu.2013.98","volume":"27","author":"JC Strefford","year":"2013","unstructured":"Strefford JC, Sutton L-A, Baliakas P et al (2013) Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia 27:2196\u20132199","journal-title":"Leukemia"},{"key":"6_CR43","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3324\/haematol.2016.141812","volume":"101","author":"L-A Sutton","year":"2016","unstructured":"Sutton L-A, Young E, Baliakas P et al (2016) Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors. Haematologica 101:959\u2013967","journal-title":"Haematologica"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2119\/molmed.2013.00005","volume":"19","author":"N Papakonstantinou","year":"2013","unstructured":"Papakonstantinou N, Ntoufa S, Chartomatsidou E et al (2013) Differential microRNA profiles and their functional implications in different Immunogenetic subsets of chronic lymphocytic leukemia. Mol Med 19:115\u2013123","journal-title":"Mol Med"},{"key":"6_CR45","first-page":"2955","volume":"141","author":"M Tsagiopoulou","year":"2023","unstructured":"Tsagiopoulou M, Chapaprieta V, Russi\u00f1ol N et al (2023) Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset #8 specific signature. Blood 141:2955\u20132960","journal-title":"Blood"},{"key":"6_CR46","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1002\/ijc.31999","volume":"144","author":"N Papakonstantinou","year":"2019","unstructured":"Papakonstantinou N, Ntoufa S, Tsagiopoulou M et al (2019) Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia. Int J Cancer 144:2695\u20132706","journal-title":"Int J Cancer"},{"key":"6_CR47","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2009-07-232868","volume":"115","author":"M Kanduri","year":"2010","unstructured":"Kanduri M, Cahill N, G\u00f6ransson H et al (2010) Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood 115:296\u2013305","journal-title":"Blood"},{"key":"6_CR48","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4161\/epi.22901","volume":"7","author":"M Kanduri","year":"2012","unstructured":"Kanduri M, Marincevic M, Halld\u00f3rsd\u00f3ttir AM et al (2012) Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles. Epigenetics 7:1435\u20131442","journal-title":"Epigenetics"},{"key":"6_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.771454","volume":"11","author":"M Gerousi","year":"2021","unstructured":"Gerousi M, Laidou S, Gemenetzi K et al (2021) Distinctive signaling profiles with distinct biological and clinical implications in aggressive CLL subsets with stereotyped B-cell receptor immunoglobulin. Front Oncol 11:771454","journal-title":"Front Oncol"},{"key":"6_CR50","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1182\/blood.V122.21.1616.1616","volume":"122","author":"F Maura","year":"2013","unstructured":"Maura F, Mosca L, Cutrona G et al (2013) Stereotyped subset #4 in chronic lymphocytic leukemia is associated with distinct gene and Microrna transcriptional profile. Blood 122:1616\u20131616","journal-title":"Blood"},{"key":"6_CR51","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3324\/haematol.2011.044792","volume":"96","author":"E Arvaniti","year":"2011","unstructured":"Arvaniti E, Ntoufa S, Papakonstantinou N et al (2011) Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients. Haematologica 96:1644\u20131652","journal-title":"Haematologica"},{"key":"6_CR52","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2119\/molmed.2011.00480","volume":"18","author":"S Ntoufa","year":"2012","unstructured":"Ntoufa S, Vardi A, Papakonstantinou N et al (2012) Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors. Mol Med 18:1281\u20131291","journal-title":"Mol Med"},{"key":"6_CR53","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/s41375-018-0335-2","volume":"33","author":"M Gounari","year":"2019","unstructured":"Gounari M, Ntoufa S, Gerousi M et al (2019) Dichotomous Toll-like receptor responses in chronic lymphocytic leukemia patients under ibrutinib treatment. Leukemia 33:1030\u20131051","journal-title":"Leukemia"},{"key":"6_CR54","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.4049\/jimmunol.1502297","volume":"196","author":"S Ntoufa","year":"2016","unstructured":"Ntoufa S, Papakonstantinou N, Apollonio B et al (2016) B cell anergy modulated by TLR1\/2 and the miR-17\u223c92 cluster underlies the indolent clinical course of chronic lymphocytic leukemia stereotyped subset #4. J Immunol 196:4410\u20134417","journal-title":"J Immunol"},{"key":"6_CR55","doi-asserted-by":"publisher","first-page":"15746","DOI":"10.1038\/ncomms15746","volume":"8","author":"C Minici","year":"2017","unstructured":"Minici C, Gounari M, \u00dcbelhart R et al (2017) Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia. Nat Commun 8:15746","journal-title":"Nat Commun"},{"key":"6_CR56","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1182\/blood-2014-09-600874","volume":"125","author":"P Baliakas","year":"2015","unstructured":"Baliakas P, Agathangelidis A, Hadzidimitriou A et al (2015) Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations. Blood 125:856\u2013859","journal-title":"Blood"},{"key":"6_CR57","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1016\/S2352-3026(14)00005-2","volume":"1","author":"P Baliakas","year":"2014","unstructured":"Baliakas P, Hadzidimitriou A, Sutton L-A et al (2014) Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study. Lancet Haemat 1:e74\u2013e84","journal-title":"Lancet Haemat"},{"key":"6_CR58","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ajh.23591","volume":"89","author":"I Del Giudice","year":"2014","unstructured":"Del Giudice I, Chiaretti S, Santangelo S et al (2014) Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients\u2019 prognosis. Am J Hematol 89:74\u201382","journal-title":"Am J Hematol"},{"key":"6_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024313","volume":"6","author":"F Maura","year":"2011","unstructured":"Maura F, Cutrona G, Fabris S et al (2011) Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia. PLoS One 6:e24313","journal-title":"PLoS One"},{"key":"6_CR60","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-08-3266","volume":"15","author":"D Rossi","year":"2009","unstructured":"Rossi D, Spina V, Cerri M et al (2009) Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res 15:4415\u20134422","journal-title":"Clin Cancer Res"},{"key":"6_CR61","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1158\/1078-0432.CCR-16-3100","volume":"23","author":"A Xochelli","year":"2017","unstructured":"Xochelli A, Baliakas P, Kavakiotis I et al (2017) Chronic lymphocytic leukemia with mutated IGHV4-34 receptors: shared and distinct Immunogenetic features and clinical outcomes. Clin Cancer Res 23:5292\u20135301","journal-title":"Clin Cancer Res"},{"key":"6_CR62","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.3324\/haematol.2017.182634","volume":"103","author":"P Baliakas","year":"2018","unstructured":"Baliakas P, Mattsson M, Hadzidimitriou A et al (2018) No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy. Haematologica 103:e158\u2013e161","journal-title":"Haematologica"},{"key":"6_CR63","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1073\/pnas.1913810117","volume":"117","author":"PC Maity","year":"2020","unstructured":"Maity PC, Bilal M, Koning MT et al (2020) IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling. Proc Natl Acad Sci USA 117:4320\u20134327","journal-title":"Proc Natl Acad Sci USA"},{"key":"6_CR64","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1182\/blood.2020008311","volume":"137","author":"F Nadeu","year":"2021","unstructured":"Nadeu F, Royo R, Clot G et al (2021) IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics. Blood 137:2935\u20132946","journal-title":"Blood"},{"key":"6_CR65","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1182\/blood-2021-152319","volume":"138","author":"P Hillmen","year":"2021","unstructured":"Hillmen P, Pitchford A, Bloor A et al (2021) Ibrutinib Plus Rituximab is superior to FCR in previously untreated CLL: results of the phase III NCRI FLAIR trial. Blood 138:642\u2013642","journal-title":"Blood"},{"key":"6_CR66","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.3324\/haematol.2019.231027","volume":"105","author":"S Jaramillo","year":"2020","unstructured":"Jaramillo S, Agathangelidis A, Schneider C et al (2020) Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG). Haematologica 105:2598\u20132607","journal-title":"Haematologica"},{"key":"6_CR67","first-page":"2955","volume":"141","author":"M Tsagiopoulou","year":"2023","unstructured":"Tsagiopoulou M, Chapaprieta V, Russi\u00f1ol N et al (2023) Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8-specific signature. Blood 141:2955\u20132960","journal-title":"Blood"},{"key":"6_CR68","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1182\/blood-2014-09-603217","volume":"125","author":"M Gounari","year":"2015","unstructured":"Gounari M, Ntoufa S, Apollonio B et al (2015) Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8. Blood 125:3580\u20133587","journal-title":"Blood"},{"key":"6_CR69","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1182\/blood-2009-06-225813","volume":"115","author":"F Forconi","year":"2010","unstructured":"Forconi F, Potter KN, Wheatley I et al (2010) The normal IGHV1-69\u2013derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. Blood 115:71\u201377","journal-title":"Blood"},{"key":"6_CR70","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1182\/blood-2007-02-073130","volume":"111","author":"GF Widhopf","year":"2008","unstructured":"Widhopf GF, Goldberg CJ, Toy TL et al (2008) Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3. Blood 111:3137\u20133144","journal-title":"Blood"},{"key":"6_CR71","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","volume":"117","author":"N Chiorazzi","year":"2011","unstructured":"Chiorazzi N, Ferrarini M (2011) Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 117:1781\u20131791","journal-title":"Blood"},{"key":"6_CR72","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1474-9726.2008.00443.x","volume":"8","author":"KL Gibson","year":"2009","unstructured":"Gibson KL, Wu Y-C, Barnett Y et al (2009) B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 8:18\u201325","journal-title":"Aging Cell"},{"key":"6_CR73","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/rej.2006.9.149","volume":"9","author":"G Colonna-Romano","year":"2006","unstructured":"Colonna-Romano G, Aquino A, Bulati M et al (2006) Memory B cell subpopulations in the aged. Rejuvenation Res 9:149\u2013152","journal-title":"Rejuvenation Res"},{"key":"6_CR74","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12979-019-0163-x","volume":"16","author":"AF Muggen","year":"2019","unstructured":"Muggen AF, de Jong M, Wolvers-Tettero ILM et al (2019) The presence of CLL-associated stereotypic B cell receptors in the normal BCR repertoire from healthy individuals increases with age. Immun Ageing 16:22","journal-title":"Immun Ageing"},{"key":"6_CR75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s10020-020-00151-9","volume":"26","author":"M Colombo","year":"2020","unstructured":"Colombo M, Bagnara D, Reverberi D et al (2020) Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach. Mol Med 26:25","journal-title":"Mol Med"},{"key":"6_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.894419","volume":"12","author":"D Bagnara","year":"2022","unstructured":"Bagnara D, Colombo M, Reverberi D et al (2022) Characterizing features of human circulating B cells carrying CLL-like stereotyped immunoglobulin rearrangements. Front Oncol 12:894419","journal-title":"Front Oncol"},{"key":"6_CR77","doi-asserted-by":"publisher","first-page":"1112879","DOI":"10.3389\/fonc.2023.1112879","volume":"13","author":"S Vergani","year":"2023","unstructured":"Vergani S, Bagnara D, Agathangelidis A et al (2023) CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: apparent lack of central and early peripheral tolerance censoring. Front Oncol 13:1112879","journal-title":"Front Oncol"},{"key":"6_CR78","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1158\/0008-5472.CAN-14-0630","volume":"74","author":"A Vardi","year":"2014","unstructured":"Vardi A, Agathangelidis A, Sutton L-A et al (2014) Immunogenetic studies of chronic lymphocytic leukemia: revelations and speculations about ontogeny and clinical evolution. Cancer Res 74:4211\u20134216","journal-title":"Cancer Res"},{"key":"6_CR79","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood.2021012890","volume":"139","author":"PM Kolijn","year":"2022","unstructured":"Kolijn PM, Hosnijeh FS, Sp\u00e4th F et al (2022) High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. Blood 139:1557\u20131563","journal-title":"Blood"},{"key":"6_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.769612","volume":"11","author":"C Galigalidou","year":"2021","unstructured":"Galigalidou C, Zaragoza-Infante L, Iatrou A et al (2021) Understanding monoclonal B cell lymphocytosis: an interplay of genetic and microenvironmental factors. Front Oncol 11:769612","journal-title":"Front Oncol"},{"key":"6_CR81","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/leu.2009.287","volume":"24","author":"TD Shanafelt","year":"2010","unstructured":"Shanafelt TD, Ghia P, Lanasa MC et al (2010) Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 24:512\u2013520","journal-title":"Leukemia"},{"key":"6_CR82","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1182\/blood-2003-09-3277","volume":"103","author":"P Ghia","year":"2004","unstructured":"Ghia P, Prato G, Scielzo C et al (2004) Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 103:2337\u20132342","journal-title":"Blood"},{"key":"6_CR83","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1056\/NEJMoa075290","volume":"359","author":"AC Rawstron","year":"2008","unstructured":"Rawstron AC, Bennett FL, O\u2019Connor SJM et al (2008) Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 359:575\u2013583","journal-title":"N Engl J Med"},{"key":"6_CR84","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/leu.2011.117","volume":"25","author":"MC Lanasa","year":"2011","unstructured":"Lanasa MC, Allgood SD, Slager SL et al (2011) Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL. Leukemia 25:1459\u20131466","journal-title":"Leukemia"},{"key":"6_CR85","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.1182\/blood-2011-05-357251","volume":"118","author":"C Fazi","year":"2011","unstructured":"Fazi C, Scarf\u00f2 L, Pecciarini L et al (2011) General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. Blood 118:6618\u20136625","journal-title":"Blood"},{"key":"6_CR86","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3324\/haematol.2017.183954","volume":"103","author":"I Criado","year":"2018","unstructured":"Criado I, Rodr\u00edguez-Caballero A, Guti\u00e9rrez ML et al (2018) Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome. Haematologica 103:1198\u20131208","journal-title":"Haematologica"},{"key":"6_CR87","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3324\/haematol.2011.053090","volume":"97","author":"S Rasi","year":"2012","unstructured":"Rasi S, Monti S, Spina V et al (2012) Analysis of NOTCH1 mutations in monoclonal B-cell lymphocytosis. Haematologica 97:153\u2013154","journal-title":"Haematologica"},{"key":"6_CR88","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/hon.2013","volume":"31","author":"M Greco","year":"2013","unstructured":"Greco M, Capello D, Bruscaggin A et al (2013) Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis. Hematol Oncol 31:54\u201355","journal-title":"Hematol Oncol"},{"key":"6_CR89","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/bjh.12800","volume":"165","author":"M Lionetti","year":"2014","unstructured":"Lionetti M, Fabris S, Cutrona G et al (2014) High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications. Br J Haematol 165:629\u2013639","journal-title":"Br J Haematol"},{"key":"6_CR90","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3324\/haematol.2017.177212","volume":"103","author":"A Agathangelidis","year":"2018","unstructured":"Agathangelidis A, Ljungstr\u00f6m V, Scarf\u00f2 L et al (2018) Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations. Haematologica 103:865\u2013873","journal-title":"Haematologica"},{"key":"6_CR91","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.1158\/1078-0432.CCR-13-0622","volume":"19","author":"F Morabito","year":"2013","unstructured":"Morabito F, Mosca L, Cutrona G et al (2013) Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: a comparison of cellular, cytogenetic, molecular, and clinical features. Clin Cancer Res 19:5890\u20135900","journal-title":"Clin Cancer Res"},{"key":"6_CR92","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07711.x","volume":"146","author":"D Rossi","year":"2009","unstructured":"Rossi D, Sozzi E, Puma A et al (2009) The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol 146:64\u201375","journal-title":"Br J Haematol"},{"key":"6_CR93","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3324\/haematol.2020.247908","volume":"106","author":"A Agathangelidis","year":"2020","unstructured":"Agathangelidis A, Galigalidou C, Scarf\u00f2 L et al (2020) Infrequent \u201cchronic lymphocytic leukemia-specific\u201d immunoglobulin stereotypes in aged individuals with or without low-count monoclonal B-cell lymphocytosis. Haematologica 106:1178\u20131181","journal-title":"Haematologica"},{"key":"6_CR94","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1182\/blood-2002-11-3479","volume":"101","author":"SH Walsh","year":"2003","unstructured":"Walsh SH, Thors\u00e9lius M, Johnson A et al (2003) Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood 101:4047\u20134054","journal-title":"Blood"},{"key":"6_CR95","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1034\/j.1600-0609.2002.01662.x","volume":"68","author":"M Thors\u00e9lius","year":"2002","unstructured":"Thors\u00e9lius M, Walsh S, Eriksson I et al (2002) Somatic hypermutation and V(H) gene usage in mantle cell lymphoma. Eur J Haematol 68:217\u2013224","journal-title":"Eur J Haematol"},{"key":"6_CR96","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/modpathol.2008.199","volume":"22","author":"M Schraders","year":"2009","unstructured":"Schraders M, Oeschger S, Kluin PM et al (2009) Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity. Mod Pathol 22:416\u2013425","journal-title":"Mod Pathol"},{"key":"6_CR97","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","volume":"101","author":"J Orchard","year":"2003","unstructured":"Orchard J, Garand R, Davis Z et al (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 101:4975\u20134981","journal-title":"Blood"},{"key":"6_CR98","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1182\/blood-2003-05-1383","volume":"102","author":"D Kienle","year":"2003","unstructured":"Kienle D, Kr\u00f6ber A, Katzenberger T et al (2003) VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood 102:3003\u20133009","journal-title":"Blood"},{"key":"6_CR99","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1182\/blood-2002-11-3456","volume":"101","author":"FI Camacho","year":"2003","unstructured":"Camacho FI, Algara P, Rodr\u00edguez A et al (2003) Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. Blood 101:4042\u20134046","journal-title":"Blood"},{"key":"6_CR100","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","volume":"118","author":"A Hadzidimitriou","year":"2011","unstructured":"Hadzidimitriou A, Agathangelidis A, Darzentas N et al (2011) Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood 118:3088\u20133095","journal-title":"Blood"},{"key":"6_CR101","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.ajpath.2017.02.017","volume":"187","author":"E Pouliou","year":"2017","unstructured":"Pouliou E, Xochelli A, Kanellis G et al (2017) Numerous ontogenetic roads to mantle cell lymphoma: Immunogenetic and Immunohistochemical evidence. Am J Pathol 187:1454\u20131458","journal-title":"Am J Pathol"},{"key":"6_CR102","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ajpath.2015.02.006","volume":"185","author":"A Xochelli","year":"2015","unstructured":"Xochelli A, Sutton L-A, Agathangelidis A et al (2015) Molecular evidence for antigen drive in the natural history of mantle cell lymphoma. Am J Pathol 185:1740\u20131748","journal-title":"Am J Pathol"},{"key":"6_CR103","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.semcancer.2011.09.009","volume":"21","author":"A Agathangelidis","year":"2011","unstructured":"Agathangelidis A, Hadzidimitriou A, Rosenquist R, Stamatopoulos K (2011) Unlocking the secrets of immunoglobulin receptors in mantle cell lymphoma: implications for the origin and selection of the malignant cells. Semin Cancer Biol 21:299\u2013307","journal-title":"Semin Cancer Biol"},{"key":"6_CR104","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","volume":"72","author":"A Navarro","year":"2012","unstructured":"Navarro A, Clot G, Royo C et al (2012) Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Cancer Res 72:5307\u20135316","journal-title":"Cancer Res"},{"key":"6_CR105","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1306220","volume":"369","author":"ML Wang","year":"2013","unstructured":"Wang ML, Rule S, Martin P et al (2013) Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N Engl J Med 369:507\u2013516","journal-title":"N Engl J Med"},{"key":"6_CR106","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/leu.2012.3","volume":"26","author":"V Bikos","year":"2012","unstructured":"Bikos V, Darzentas N, Hadzidimitriou A et al (2012) Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. Leukemia 26:1638\u20131646","journal-title":"Leukemia"},{"key":"6_CR107","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3324\/haematol.2010.025437","volume":"95","author":"S Zibellini","year":"2010","unstructured":"Zibellini S, Capello D, Forconi F et al (2010) Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. Haematologica 95:1792\u20131796","journal-title":"Haematologica"},{"key":"6_CR108","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1158\/1078-0432.CCR-15-1170","volume":"22","author":"V Bikos","year":"2016","unstructured":"Bikos V, Karypidou M, Stalika E et al (2016) An Immunogenetic signature of ongoing antigen interactions in splenic marginal zone lymphoma expressing IGHV1-2*04 receptors. Clin Cancer Res 22:2032\u20132040","journal-title":"Clin Cancer Res"},{"key":"6_CR109","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/path.5209","volume":"247","author":"A Xochelli","year":"2019","unstructured":"Xochelli A, Bikos V, Polychronidou E et al (2019) Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations. J Pathol 247:416\u2013421","journal-title":"J Pathol"},{"key":"6_CR110","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1074-7613(00)00006-6","volume":"13","author":"JL Xu","year":"2000","unstructured":"Xu JL, Davis MM (2000) Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13:37\u201345","journal-title":"Immunity"},{"key":"6_CR111","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/jmr.679","volume":"17","author":"Y Barrios","year":"2004","unstructured":"Barrios Y, Jirholt P, Ohlin M (2004) Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. J Mol Recognit 17:332\u2013338","journal-title":"J Mol Recognit"},{"key":"6_CR112","doi-asserted-by":"publisher","first-page":"W503","DOI":"10.1093\/nar\/gkn316","volume":"36","author":"X Brochet","year":"2008","unstructured":"Brochet X, Lefranc M-P, Giudicelli V (2008) IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 36:W503\u2013W508","journal-title":"Nucleic Acids Res"},{"key":"6_CR113","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/978-1-61779-842-9_32","volume":"882","author":"E Alamyar","year":"2012","unstructured":"Alamyar E, Duroux P, Lefranc M-P, Giudicelli V (2012) IMGT(\u00ae) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT\/V-QUEST and IMGT\/HighV-QUEST for NGS. Meth Mol Biol 882:569\u2013604","journal-title":"Meth Mol Biol"},{"key":"6_CR114","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/prot.340170108","volume":"17","author":"S Henikoff","year":"1993","unstructured":"Henikoff S, Henikoff JG (1993) Performance evaluation of amino acid substitution matrices. Proteins 17:49\u201361","journal-title":"Proteins"},{"key":"6_CR115","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btv456","volume":"31","author":"V Bystry","year":"2015","unstructured":"Bystry V, Agathangelidis A, Bikos V et al (2015) ARResT\/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy. Bioinformatics 31:3844\u20133846","journal-title":"Bioinformatics"},{"key":"6_CR116","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2013-02-486209","volume":"121","author":"D Rossi","year":"2013","unstructured":"Rossi D, Spina V, Bomben R et al (2013) Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. Blood 121:4902\u20134905","journal-title":"Blood"},{"key":"6_CR117","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1182\/blood.2020005216","volume":"137","author":"K Gemenetzi","year":"2021","unstructured":"Gemenetzi K, Psomopoulos F, Carriles AA et al (2021) Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169. Blood 137:1895\u20131904","journal-title":"Blood"},{"key":"6_CR118","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12859-018-2381-1","volume":"19","author":"E Polychronidou","year":"2018","unstructured":"Polychronidou E, Kalamaras I, Agathangelidis A et al (2018) Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia. BMC Bioinform 19:414","journal-title":"BMC Bioinform"},{"key":"6_CR119","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1038\/s41375-020-0923-9","volume":"34","author":"F Davi","year":"2020","unstructured":"Davi F, Langerak AW, de Septenville AL et al (2020) Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing. Leukemia 34:2545\u20132551","journal-title":"Leukemia"},{"key":"6_CR120","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1038\/s41375-023-01952-7","volume":"37","author":"E Sofou","year":"2023","unstructured":"Sofou E, Vlachonikola E, Zaragoza-Infante L et al (2023) Clonotype definitions for immunogenetic studies: proposals from the EuroClonality NGS Working Group. Leukemia 37:1750\u20131752","journal-title":"Leukemia"}],"container-title":["Methods in Molecular Biology","Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4188-0_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T19:02:27Z","timestamp":1729278147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4188-0_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"ISBN":["9781071641873","9781071641880"],"references-count":120,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4188-0_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,19]]},"assertion":[{"value":"19 October 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}